# Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.

> **NCT05987033** · PHASE1,PHASE2 · COMPLETED · sponsor: **Novadip Biosciences** · enrollment: 11 (actual)

## Conditions studied

- Distal Radius Fractures

## Interventions

- **DRUG:** NVDX3

## Key facts

- **NCT ID:** NCT05987033
- **Lead sponsor:** Novadip Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-08
- **Primary completion:** 2024-12-19
- **Final completion:** 2024-12-19
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05987033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05987033, "Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05987033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*